Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019 Jacob Romano; Jessica Burnside; Giada Sebastiani; Alnoor Ramji; Keyur Patel; Mark Swain; Sahar Saeed;

The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease Francisco Barrera; Javier Uribe; Nixa Olvares; Paula Huerta; Daniel Cabrera; Manuel Romero-Gómez;

Optimal ALT threshold for the automated diagnosis of MASLD: A population-based study using iLFT Jeremy Lee; Christopher J. Byrne; Paul N. Brennan; Iain MacPherson; Eleanor Dow; John F. Dillon;